Top 5 Stocks to Buy Now
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable

Recent News About These Companies

Abattis Bioceuticals Stock Price History
May 27, 2025  |  investing.comhttps://www.investing.com/equities/abattis-bioceuticals-historical-data
Abattis Bioceuticals Corp. (ATTBF)
August 2, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/ATTBF/news/
B.C. investment dealer that oversaw suspicious, 'unprofitable' trades fined $150K
February 14, 2024  |  richmond-news.comR
B.C. investment dealer who oversaw suspicious, 'unprofitable' trades fined $150K
February 13, 2024  |  vancouverisawesome.comV
Minoxidil Price of 85 Brands
August 1, 2023  |  medindia.netM
Abattis Bioceuticals Stock (OTC:ATTBF), Quotes and News Summary
February 23, 2023  |  benzinga.comhttps://www.benzinga.com/quote/ATTBF
Malaysian Bulk Carriers Bhd (MBCB)
July 26, 2022  |  investing.comhttps://www.investing.com/equities/malaysian-bulk-carriers-bhd
Metrc Enters Government Contract With The State Of South Dakota
March 24, 2022  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/22/03/26256990/metrc-enters-government-contract-with-the-state-of-south-dakota
Cann American Cancels Over 3 Million Common Shares
March 5, 2022  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/22/03/25987493/cann-american-cancels-over-3-million-common-shares
Last Prisoner Project Calls For Support Of Rudi Gammo, Imprisoned For Operating A Medical Cannabis Dispensary
September 1, 2021  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/21/08/22722393/last-prisoner-project-calls-for-support-of-rudi-gammo-imprisoned-for-operating-a-medical-cannabi
Hollister Biosciences Stock Down Slightly On $17.6M Q2 2021 Revenue Report, $3.2M Of Adjusted EBITDA
August 27, 2021  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/21/08/22678038/hollister-biosciences-stock-down-slightly-on-17-6m-q2-2021-revenue-report-3-2m-of-adjusted-ebitd

Top Headlines

View All Headlines
SpaceX logo overlaid on a Falcon 9 rocket launching from a coastal pad at sunset.
SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
By Bridget Bennett | May 25, 2026
Close-up of rare earth metal sample over stock chart, symbolizing USA Rare Earth volatility and market movement.
3 Rare Earth Stocks That Win No Matter What China Does Next
By Bridget Bennett | May 24, 2026
Microsoft cloud logo glows amid a digital grid over a cityscape, underscoring the company’s expanding AI momentum.
Microsoft Stock Discount May Be Ending as AI Catalysts Build
By Chris Markoch | May 25, 2026
SpaceX logo overlaid on a Falcon 9 rocket on a launch pad at dusk.
SpaceX Rings the Bell and Shatters Every Record
By Jeffrey Neal Johnson | June 12, 2026
A laptop on a desk displays a financial news page for the Amplify Cybersecurity ETF (HACK) with price data.
As AI Data Breaches Become More Common, This Cybersecurity ETF Is Surging
By Jessica Mitacek | June 4, 2026

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas